Patient satisfaction with two different management modalities for erratic bleeding during continuous hormone therapy for endometriosis-associated symptoms: A before-after study
Observational
OA: closed
CC0
AI-generated summary
This before-after study compared patient satisfaction with two different management approaches for unpredictable bleeding during continuous hormone therapy for endometriosis symptoms.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate patient satisfaction with the management of erratic bleeding during continuous hormone therapy for endometriosis using two different strategies: an active approach (tailored cycling), which involved discontinuation of the therapy; and a passive approach, which involved waiting for spontaneous resolution of the bleeding.
METHODS: This was an observational before-after study. All patients enrolled within a previously defined time limit were instructed to adopt a passive strategy to manage erratic bleeding, while all patients enrolled after that defined time were instructed to discontinue therapy for 7 days (tailored cycling). Degree of satisfaction, characteristics of bleeding, and level of dysmenorrhoea were compared and analysed at the time of enrolment and after 6 and 12 months.
RESULTS: In total, 201 patients were included in the study. Satisfaction was 29% higher among patients in the passive strategy group compared with those in the tailored cycling group; this difference was significant. No significant differences were identified for the other outcomes.
CONCLUSION: Patients may be more satisfied with the use of a passive approach to manage irregular bleeding during continuous hormone therapy for endometriosis-associated pain. All patients should be provided with comprehensive information regarding all available management strategies for unpredictable irregular bleeding. This will enable patients to make informed decisions based on their personal experience and preferences, without external pressure, thus improving compliance, adherence and, ideally, satisfaction with treatment.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (36)
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Continuous use of oral contraceptives: an overview of effects and side-effects via openalex
- Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis via openalex
- Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review via openalex
- Endometriosis via openalex
- Endometriosis: epidemiology and aetiological factors via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- Estrogen-progestins and progestins for the management of endometriosis via openalex
- Hormonal contraception in women with endometriosis: a systematic review via openalex
- Modifiable life style factors and risk for incident endometriosis via openalex
- Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex
- Systematic review of endometriosis pain assessment: how to choose a scale? via openalex
- Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate via openalex
- Unscheduled vaginal bleeding with progestin-only contraceptive use via openalex
- W2531495452 via openalex
- W2599076725 via openalex
- W3083911904 via openalex
- W4214754424 via openalex
- W6607062396 via openalex
- W6649972215 via openalex
- W6663760826 via openalex
- W172464606 via openalex
- W6676800299 via openalex
- W1976456116 via openalex
- W2006746730 via openalex
- W2020206174 via openalex
- W2022534203 via openalex
- W2028839906 via openalex
- W2041557786 via openalex
- W2047372977 via openalex
- W2053056751 via openalex
- W2067721206 via openalex
- W2089566107 via openalex
- W2113520440 via openalex
- W2114428420 via openalex
- W2327924145 via openalex
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-13T06:07:03.027252+00:00
License: CC0
· commercial use OK